Results 61 to 70 of about 56,164 (204)

2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts [PDF]

open access: yes, 2014
Platelets modulate vascular system integrity, and their loss is critical in haematological pathologies and after chemotherapy. Therefore, identification of molecules enhancing platelet production would be useful to counteract thrombocytopenia.
Gasperi, V   +18 more
core   +1 more source

Human platelet antigen polymorphisms and the risk of chronic Chagas disease cardiomyopathy

open access: yesPlatelets, 2020
Human platelet antigen (HPA) polymorphisms are considered to be a risk factor for cardiac and vascular diseases, but the role of HPA in chronic Chagas disease cardiomyopathy (CCC) is not available.
Deborah Elzita do Carmo Corrêa   +8 more
doaj   +1 more source

Laboratory analyses for evaluation of platelet disorders and platelet concentrates

open access: yes, 2006
High quality of platelet analytics requires specialized knowledge and skills. It was applied to analyze platelet activation and aggregation responses in a prospective controlled study of patients with Finnish type of amyloidosis.
Javela, Kaija
core  

Unlocked nucleic acid modified primer-based enzymatic polymerization assay: Towards allele-specific genotype detection of human platelet antigens [PDF]

open access: yes, 2018
Accurate detection of single nucleotide polymorphisms (SNPs) is paramount for the appropriate therapeutic intervention of debilitating diseases associated with SNPs.
Jørgensen, Per T.   +13 more
core   +1 more source

In vitro expression analysis of the ITGB3 c.598G/A mutation and its association with FNAIT

open access: yesZhongguo shuxue zazhi
[Objective] To explore the role of the c.598G>A mutation of the ITGB3 gene in the occurrence of fetal and neonatal alloimmune thrombocytopenia (FNAIT) through its expression in vitro.
DING Haoqiang   +8 more
doaj   +1 more source

Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions Frequência dos antígenos plaquetários humanos (HPA) em pacientes trombocitopênicos e predisposição à incompatibilidade transfusional

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2012
OBJECTIVE: The objective of this study was to evaluate the frequencies of human platelet antigens in oncohematological patients with thrombocytopenia and to analyze the probability of their incompatibility with platelet transfusions.
Juliana Vieira dos Santos Bianchi   +4 more
doaj   +1 more source

Novel method for simultaneously detecting HPA and HLA antibodies using Luminex microbeads

open access: yesJournal of Translational Medicine, 2019
Background Alloantibodies against human platelet antigens (HPAs) and human leukocyte antigen (HLA) are implicated in several immune-mediated platelet disorders.
Sudan Tao   +4 more
doaj   +1 more source

Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics

open access: yesPlatelets
Although there have been tremendous improvements in the production and storage of platelets, platelet transfusion refractoriness (PTR) remains a serious clinical issue that may lead to various severe adverse events.
Xiaoyu Chen   +3 more
doaj   +1 more source

Purification and partial characterization of CD9 antigen of human platelets

open access: yesFEBS Letters, 1990
CD9 antigen (p24) was purified from human platelets and partially characterized. The yield was 75 μg from 10 units of platelet concentrates. p24 (38 000 copies/platelet) has intramolecular disulfide bond(s) and, in SDS‐PAGE, consists of major 24‐kDa molecule and minor 26‐ to 31‐kDa molecules.
Higashihara, Masaaki   +4 more
openaire   +2 more sources

Platelet compatibility and platelet antibodies detection: A step towards resolving dilemma in management of platelet refractoriness in oncology patients

open access: yesGlobal Journal of Transfusion Medicine, 2019
Background: Platelet refractoriness complicates the provision of platelet transfusions- a critical and essential part in management of thrombocytopenia in Oncology patients. Platelet refractoriness poses challenge due to alloimmunization to HLA (Class I)
Sadhana Mangwana   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy